MISSISSAUGA, ON, Sept. 12 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN - News; TSX:VAS - News), a leader in the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, today announced that its President and Chief Executive Officer, David Elsley, will present a Company overview at the A.G. Edwards' Emerging Growth Conference 2006 on Wednesday, September 20, at 10:30 a.m. ET at the New York Palace Hotel.
